Literature DB >> 8484704

Folate supplementation and methotrexate.

S L Morgan, J E Baggott, W J Koopman, C L Krumdieck, G S Alarcón.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8484704      PMCID： PMC1005636          DOI： 10.1136/ard.52.4.315-b

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  10 in total

Review 1.  Does folate supplementation make sense in patients with rheumatoid arthritis treated with methotrexate?

Authors:  A A Stenger; P M Houtman; G A Bruyn
Journal:  Ann Rheum Dis       Date:  1992-08       Impact factor: 19.103

2.  The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis.

Authors:  S L Morgan; J E Baggott; W H Vaughn; P K Young; J V Austin; C L Krumdieck; G S Alarcón
Journal:  Arthritis Rheum       Date:  1990-01

3.  Suppression of rheumatoid factor production by methotrexate in patients with rheumatoid arthritis. Evidence for differential influences of therapy and clinical status on IgM and IgA rheumatoid factor expression.

Authors:  G S Alarcón; R E Schrohenloher; A A Bartolucci; J R Ward; H J Williams; W J Koopman
Journal:  Arthritis Rheum       Date:  1990-08

4.  Weekly pulse methotrexate in rheumatoid arthritis. Clinical and immunologic effects in a randomized, double-blind study.

Authors:  P A Andersen; S G West; J R O'Dell; C S Via; R G Claypool; B L Kotzin
Journal:  Ann Intern Med       Date:  1985-10       Impact factor: 25.391

5.  Folate supplementation in methotrexate-treated rheumatoid arthritis patients.

Authors:  K A Stewart; A H Mackenzie; J D Clough; W S Wilke
Journal:  Semin Arthritis Rheum       Date:  1991-04       Impact factor: 5.532

6.  Methotrexate therapy in rheumatoid arthritis patients diminishes lectin-induced mononuclear cell proliferation.

Authors:  R J Hine; M P Everson; J M Hardin; S L Morgan; G S Alarcòn; J E Baggott; W J Koopman; C L Krumdieck
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

7.  Concurrent use of folinic acid and methotrexate in rheumatoid arthritis.

Authors:  P S Hanrahan; A S Russell
Journal:  J Rheumatol       Date:  1988-07       Impact factor: 4.666

8.  The effects of leucovorin (folinic acid) on methotrexate therapy in rheumatoid arthritis patients.

Authors:  M Tishler; D Caspi; B Fishel; M Yaron
Journal:  Arthritis Rheum       Date:  1988-07

9.  Immunologic studies of rheumatoid arthritis patients treated with methotrexate.

Authors:  N J Olsen; L F Callahan; T Pincus
Journal:  Arthritis Rheum       Date:  1987-05

10.  Inhibition of 5-aminoimidazole-4-carboxamide ribotide transformylase, adenosine deaminase and 5'-adenylate deaminase by polyglutamates of methotrexate and oxidized folates and by 5-aminoimidazole-4-carboxamide riboside and ribotide.

Authors:  J E Baggott; W H Vaughn; B B Hudson
Journal:  Biochem J       Date:  1986-05-15       Impact factor: 3.857
  10 in total
  3 in total

Review 1.  Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases.

Authors:  Bruce N Cronstein; Michail Sitkovsky
Journal:  Nat Rev Rheumatol       Date:  2016-11-10       Impact factor: 20.543

2.  A personal journey from the joint to the heart.

Authors:  Bruce N Cronstein
Journal:  Arthritis Res Ther       Date:  2010-08-13       Impact factor: 5.156

3.  Reducing Immunogenicity of Pegloticase With Concomitant Use of Mycophenolate Mofetil in Patients With Refractory Gout: A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Puja P Khanna; Dinesh Khanna; Gary Cutter; Jeff Foster; Joshua Melnick; Sara Jaafar; Stephanie Biggers; A K M Fazlur Rahman; Hui-Chien Kuo; Michelle Feese; Alan Kivitz; Charles King; William Shergy; Jeff Kent; Paul M Peloso; Maria I Danila; Kenneth G Saag
Journal:  Arthritis Rheumatol       Date:  2021-05-19       Impact factor: 15.483
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.